Quick Answer
Krystal Biotech, Inc. reported Stockholders Equity of $1.22 billion for fiscal year 2025.
Krystal Biotech, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.22B | +28.9% |
| 2024 | $946.38M | +21.5% |
| 2023 | $778.64M | +49.1% |
| 2022 | $522.23M | -12.0% |
| 2021 | $593.58M | +103.2% |
| 2020 | $292.08M | +43.9% |
| 2019 | $202.91M | +79.2% |
| 2018 | $113.23M | +128.9% |
| 2017 | $49.47M | +17019.0% |
| 2016 | $289.0K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.14B | +28.5% | +9.3% |
| June 30, 2025 | $1.04B | +24.1% | +5.7% |
| March 31, 2025 | $984.67M | +23.2% | +4.0% |
| December 31, 2024 | $946.38M | +21.5% | +6.8% |
| September 30, 2024 | $885.85M | +17.2% | +5.6% |
| June 30, 2024 | $838.89M | +28.4% | +5.0% |
| March 31, 2024 | $799.24M | +63.3% | +2.6% |
| December 31, 2023 | $778.64M | +49.1% | +3.0% |
- Krystal Biotech, Inc. showed an increase of +28.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, Krystal Biotech, Inc.’s stockholders equity has grown by 421893.1% (from $289.0 thousand to $1.22 billion).
- The most recent figure is from Krystal Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: